A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells-Reference-Cited by-同舟云学术

A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells

Published:2023-08 Issue:8 Volume:31 Page:2472-2488
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Cook Peter J.,Yang Su Jung,Uenishi Gene I.,Grimm Annaiz,West Samuel E.,Wang Li-Jie,Jacobs Chester,Repele Andrea,Drow Travis,Boukhris Ahmad,Dahl Noelle P.,Sommer Karen,Scharenberg Andrew M.,Rawlings David J.^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference48 articles.

1. Chimeric antigen receptor therapy;June;N. Engl. J. Med.,2018

2. Next-generation CAR T-cell therapies;Young;Cancer Discov.,2022

3. CRISPR-engineered T cells in patients with refractory cancer;Stadtmauer;Science,2020

4. Treg cell-based therapies: challenges and perspectives;Raffin;Nat. Rev. Immunol.,2020

5. Next-generation regulatory T cell therapy;Ferreira;Nat. Rev. Drug Discov.,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of FoxP3⁺ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy;Human Gene Therapy;2024-07-01

2. Sequential immunotherapy: towards cures for autoimmunity;Nature Reviews Drug Discovery;2024-06-05

3. CRISPR–Cas9 applications in T cells and adoptive T cell therapies;Cellular & Molecular Biology Letters;2024-04-12

4. Gene editing ofCD3 epsilongene to redirect regulatory T cells for adoptive T cell transfer;2024-03-18

5. GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes;JCI Insight;2024-02-08